504 related articles for article (PubMed ID: 6143744)
1. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
2. Depot fluphenazine: risk/benefit ratio.
Glazer WM
J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
[TBL] [Abstract][Full Text] [Related]
3. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
Johnson DA
Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
[No Abstract] [Full Text] [Related]
4. Depot neuroleptics: side effects and safety.
Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
[TBL] [Abstract][Full Text] [Related]
5. Depot neuroleptic therapy: an underutilized treatment option.
Glazer WM; Kane JM
J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
[TBL] [Abstract][Full Text] [Related]
6. The use of depot neuroleptics: clinical experience in the United States.
Kane JM
J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
[TBL] [Abstract][Full Text] [Related]
7. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
Johnson DA
J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
9. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
Möller HJ; Kissling W
Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
[No Abstract] [Full Text] [Related]
10. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Citrome L; Jaffe A; Levine J
Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drug side effects: their relationship to dose.
Kane JM
J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
[TBL] [Abstract][Full Text] [Related]
12. Experience with depot neuroleptics in ambulatory practice.
Fiolet J
Acta Psychiatr Belg; 1981; 81(2):182-8. PubMed ID: 6117188
[TBL] [Abstract][Full Text] [Related]
13. [Effects and side effects of depot neuroleptics as perceived by patients].
Trenckmann U
Psychiatr Prax; 1990 Sep; 17(5):184-7. PubMed ID: 1980015
[TBL] [Abstract][Full Text] [Related]
14. Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Ereshefsky L; Saklad SR; Jann MW; Davis CM; Richards A; Seidel DR
J Clin Psychiatry; 1984 May; 45(5 Pt 2):50-9. PubMed ID: 6143748
[TBL] [Abstract][Full Text] [Related]
15. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
16. Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.
Kane JM; Woerner M; Sarantakos S
J Clin Psychiatry; 1986 May; 47 Suppl():30-3. PubMed ID: 2871014
[TBL] [Abstract][Full Text] [Related]
17. Early hospital experience with fluphenazine decanoate.
Small JG; Kellams J
Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
[TBL] [Abstract][Full Text] [Related]
18. [Depot antipsychotics in the year 2011].
Knegtering H; Oolders H; Ruijsink MA; van der Moolen AE
Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066
[TBL] [Abstract][Full Text] [Related]
19. [Prolonged action neuroleptics (review of the foreign literature)].
Obukhov GA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
[No Abstract] [Full Text] [Related]
20. Long-term treatment with neuroleptics in psychiatry.
Shepherd M; Watt DC
Curr Dev Psychopharmacol; 1977; 4():215-47. PubMed ID: 23248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
